9 Meters Biopharma Inc.

NASDAQ: NMTR · Real-Time Price · USD
0.07
-0.06 (-44.71%)
At close: Jul 25, 2023, 10:00 PM

9 Meters Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
12.65M 46.99M
Short-Term Investments
n/a n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
7.28K 5.58K
Receivables
n/a n/a
Inventory
n/a n/a
Other Current Assets
3.36M 2.99M
Total Current Assets
33.02M 49.99M
Property-Plant & Equipment
122.72K 182.71K
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
130K 188.29K
Total Assets
33.15M 50.17M
Account Payables
5.05M 2.43M
Deferred Revenue
n/a n/a
Short-Term Debt
19.68M 54.8K
Other Current Liabilities
5.96M 5.97M
Total Current Liabilities
30.7M 8.46M
Long-Term Debt
51.4K 113.14K
Other Long-Term Liabilities
n/a n/a
Total Long-Term Liabilities
51.4K 113.14K
Total Liabilities
30.75M 8.57M
Total Debt
19.73M 167.94K
Common Stock
1.3K 25.82K
Retained Earnings
-212.61M -168.84M
Comprehensive Income
n/a n/a
Shareholders Equity
2.4M 41.6M
Total Investments
n/a n/a